139 related articles for article (PubMed ID: 19834044)
1. Episcleral implants for topotecan delivery to the posterior segment of the eye.
Carcaboso AM; Chiappetta DA; Opezzo JA; Höcht C; Fandiño AC; Croxatto JO; Rubio MC; Sosnik A; Abramson DH; Bramuglia GF; Chantada GL
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2126-34. PubMed ID: 19834044
[TBL] [Abstract][Full Text] [Related]
2. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
3. Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy.
Carcaboso AM; Bramuglia GF; Chantada GL; Fandiño AC; Chiappetta DA; de Davila MT; Rubio MC; Abramson DH
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3761-7. PubMed ID: 17652749
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry.
Ghate D; Brooks W; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284
[TBL] [Abstract][Full Text] [Related]
5. Delivery from episcleral exoplants.
Pontes de Carvalho RA; Krausse ML; Murphree AL; Schmitt EE; Campochiaro PA; Maumenee IH
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4532-9. PubMed ID: 17003449
[TBL] [Abstract][Full Text] [Related]
6. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
7. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
Buitrago E; Höcht C; Chantada G; Fandiño A; Navo E; Abramson DH; Schaiquevich P; Bramuglia GF
Exp Eye Res; 2010 Jul; 91(1):9-14. PubMed ID: 20307538
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma.
Hayden BC; Jockovich ME; Murray TG; Voigt M; Milne P; Kralinger M; Feuer WJ; Hernandez E; Parel JM
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3644-9. PubMed ID: 15452072
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of periocular topotecan in children with intraocular retinoblastoma.
Chantada GL; Fandino AC; Carcaboso AM; Lagomarsino E; de Davila MT; Guitter MR; Rose AB; Manzitti J; Bramuglia GF; Abramson DH
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1492-6. PubMed ID: 18978345
[TBL] [Abstract][Full Text] [Related]
11. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
[TBL] [Abstract][Full Text] [Related]
13. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
Ranta VP; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
[TBL] [Abstract][Full Text] [Related]
14. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.
Kim SH; Galbán CJ; Lutz RJ; Dedrick RL; Csaky KG; Lizak MJ; Wang NS; Tansey G; Robinson MR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):808-14. PubMed ID: 17251481
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
[TBL] [Abstract][Full Text] [Related]
16. Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina.
Mizuno K; Koide T; Shimada S; Mori J; Sawanobori K; Araie M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2839-47. PubMed ID: 19218605
[TBL] [Abstract][Full Text] [Related]
17. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
Li J; Lan B; Li X; Sun S; Lu P; Cheng L
J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of carboplatin delivery to the eye using hydrogel-iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Dagan A; Frucht-Pery J; Pe'er J
Curr Eye Res; 2008 Mar; 33(3):269-75. PubMed ID: 18350438
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
20. Transscleral delivery of bioactive protein to the choroid and retina.
Ambati J; Gragoudas ES; Miller JW; You TT; Miyamoto K; Delori FC; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1186-91. PubMed ID: 10752959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
